Where CRI Funds

Our scientists are making breakthrough discoveries at premier institutions around the world.

Let's spread the word about Immunotherapy! Click to share this page with your community.

Copy Link

Filter By:

*Immunotherapy results may vary from patient to patient.

Contact Us

Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111

(800) 992-2623 (212) 832-9376 Staff Directory

Stay Connected with CRI

Recent Blog Posts

Nivolumab (Opdivo®) is now available for patients with metastatic and treatment-resistant small cell lung cancer

Gloria Garcia was diagnosed in 2017 with small cell lung cancer. After combination ipilimumab/nivolumab immunotherapy treatment she went into remission.